ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

SPRY ARS Pharmaceuticals Inc

9.00
-0.33 (-3.54%)
最終更新日: 00:23:20
15分遅延
名称 銘柄コード 市場 種別
ARS Pharmaceuticals Inc SPRY NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.33 -3.54% 9.00 00:23:20
始値 安値 高値 終値 前日終値
9.35 8.94 9.4909 9.33
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3022:01GLOBEARS Pharmaceuticals Submits Response for neffy® (epinephrine..
2024/4/0322:01GLOBEARS Pharmaceuticals Submits Response to FDA Complete..
2024/3/2205:05GLOBEARS Pharmaceuticals Provides Business Update and Reports..
2024/3/0806:05GLOBEARS Pharmaceuticals Reviews Recent Clinical Updates and..
2024/3/0802:56EDGAR2Form 8-K - Current report
2024/3/0623:01GLOBEARS Pharmaceuticals to Participate in the Leerink Partners..
2024/3/0210:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2702:08EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2623:01GLOBEARS Pharmaceuticals announces neffy® meets primary endpoints..
2024/2/2223:01GLOBEARS Pharmaceuticals to Host Virtual neffy® Investor Day on..
2024/2/2023:01GLOBEARS Pharma Announces Favorable Topline Results from Repeat..
2024/2/0523:01GLOBEARS Pharmaceuticals to Present Positive Clinical Efficacy..
2024/1/0506:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:02EDGAR2Form 8-K - Current report
2023/11/1006:00GLOBEARS Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/1001:02GLOBEARS Pharmaceuticals Announces Presentation of Clinical Data..
2023/10/0622:57DJNARS Pharmaceuticals to Meet With FDA on Neffy Rejection
2023/10/0622:03GLOBEARS Pharmaceuticals Announces Scheduling of a Type A Meeting..
2023/10/0322:03GLOBESingle and Repeat Dose Clinical Study of neffy (epinephrine..
2023/9/2605:17EDGAR2Form 8-K - Current report
2023/9/2023:20DJNARS Pharmaceuticals Shares Sink to New Lows on FDA Neffy..
2023/9/2019:30DJNARS Pharmaceuticals Shares Sink Premarket as FDA Rejects..
2023/9/2019:05EDGAR2Form 8-K - Current report
2023/9/2011:49GLOBEFDA Issues Complete Response Letter for neffy® (epinephrine..
2023/9/0205:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/1105:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:05EDGAR2Form 8-K - Current report
2023/8/1105:00GLOBEARS Reports Second Quarter 2023 Financial Results and..
2023/6/2910:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2910:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2905:32EDGAR2Form 8-K - Current report
2023/6/2021:00GLOBEARS Pharmaceuticals Announces PDUFA Date Extension for..
2023/5/1522:00GLOBEARS Pharmaceuticals Highlights Progress and Reports First..
2023/5/1221:55DJNARS Pharmaceuticals Soar 68% in Premarket Trading as FDA..
2023/5/1208:01GLOBEFDA Advisory Committee Votes in Support of Favorable..
2023/5/0922:10GLOBEARS Pharmaceuticals Announces Availability of Briefing..

最近閲覧した銘柄

Delayed Upgrade Clock